Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Jashalynn German"'
Autor:
Kacey Chae, Jashalynn German, Karla Kendrick, Sean Tackett, Paul O’Rourke, Kimberly A. Gudzune, Marci Laudenslager
Publikováno v:
Obesity Science & Practice, Vol 10, Iss 2, Pp n/a-n/a (2024)
Abstract Objective Despite the rising prevalence of people living with obesity, physicians are providing suboptimal care to these individuals, which may be a consequence of inadequate education in weight management and negative attitudes toward peopl
Externí odkaz:
https://doaj.org/article/0807d14a9dbd4fc8b10346310aeccde8
Autor:
Jashalynn German, Elizabeth A Kobe, Allison A Lewinski, Amy S Jeffreys, Cynthia Coffman, David Edelman, Bryan C Batch, Matthew J Crowley
Publikováno v:
J Endocr Soc
ObjectiveExamine factors associated with increased diabetes distress (DD) among patients with type 2 diabetes with DD assessed by Diabetes Distress Scale (DDS) total and subscale scores (emotional burden, physician-related distress, regimen-related d
Autor:
DIANA SOLIMAN, R. CLAYTON MUSSER, JASON P. JACKSON, JASHALYNN GERMAN, SCOTT CARLSON, KATHRYN H. ODONNELL, TRACY SETJI
Publikováno v:
Diabetes. 71
The use of sodium-glucose cotransporter-2 (SGLT2) inhibitors has recently been associated with euglycemic diabetic ketoacidosis (euDKA) . The absence of hyperglycemia can delay recognition of euDKA. We aimed to increase screening rates for euDKA by i
Publikováno v:
Diagnosis and Management of Endocrine Disorders in Interventional Radiology ISBN: 9783030871888
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06cb16ea706e6ecb9456f11aa2430d64
https://doi.org/10.1007/978-3-030-87189-5_5
https://doi.org/10.1007/978-3-030-87189-5_5
Autor:
Jashalynn German, Cynthia J. Coffman, Ryan Duffy, Elizabeth A. Kobe, Cynthia A. Moylan, Amy S. Jeffreys, Diana Soliman, Anastasia-Stefania Alexopoulos, Matthew J Crowley
Publikováno v:
Journal of the Endocrine Society
Individuals with type 2 diabetes (T2DM) are at high risk for nonalcoholic fatty liver disease (NAFLD), and evidence suggests that poor glycemic control is linked to heightened risk of progressive NAFLD. We conducted an observational study based on da
Publikováno v:
Journal of the Endocrine Society. 6:A304-A304
Background During the COVID- 19 pandemic, the use of telemedicine (virtual synchronous visits via phone or video format) to deliver health care increased significantly. Objective Explore endocrine provider experience and perspective on the use of tel
Publikováno v:
Diabetes, metabolic syndrome and obesity : targets and therapy. 15
Evidence suggests that low carbohydrate (130 g/day of carbohydrate) (LCD) and very low carbohydrate, ketogenic diets (typically50 g/day of carbohydrate) (VLCKD) can be effective tools for managing diabetes given their beneficial effects on weight los
Autor:
Cynthia J. Coffman, Amy S. Jeffreys, Elizabeth A. Kobe, David Edelman, Jashalynn German, Matthew J Crowley, Diana Soliman, Anastasia-Stefania Alexopoulos
Publikováno v:
Diabetes. 70
Background: Low health literacy (HL) is a barrier to improving health outcomes in patients with type 2 diabetes (T2DM). The Newest Vital Sign (NVS) is a validated, short questionnaire for assessing HL. The relationship between NVS HL and patient-repo
Autor:
Elizabeth A. Kobe, Allison A. Lewinski, Diana Soliman, David Edelman, Matthew J Crowley, Amy S. Jeffreys, Jashalynn German, Cynthia J. Coffman
Publikováno v:
Diabetes. 70
Diabetes distress (DD), the psychological distress specific to living with diabetes, is associated with poor glycemic control. This study sought to examine the association of diabetes distress with demographic, clinical, and psychosocial factors in a
Autor:
Elizabeth A. Kobe, Anastasia-Stefania Alexopoulos, Jashalynn German, Cynthia A. Moylan, Ryan Duffy, Matthew J Crowley, Cynthia J. Coffman, Amy S. Jeffreys, Diana Soliman
Publikováno v:
Diabetes. 70
Nonalcoholic fatty liver disease (NAFLD) and its complications disproportionately impact individuals with T2DM. NAFLD prevalence is thought to be 60-70% in T2DM. In response to this, guidelines now recommend additional liver testing and risk stratifi